| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/1999 | US5919932 Biphenylamide derivatives as 5HT1D antagonists |
| 07/06/1999 | US5919924 Process for preparing 3-halogenated cephem derivative |
| 07/06/1999 | US5919923 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 07/06/1999 | US5919916 6-O-alkyl derivatives of erythronolide B |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919832 Amine polymer sequestrant and method of cholesterol depletion |
| 07/06/1999 | US5919829 Gastrin and cck receptor ligands |
| 07/06/1999 | US5919828 Racemic propranolol |
| 07/06/1999 | US5919827 Pure isomer; side effect reduction |
| 07/06/1999 | US5919826 Synergistic mixture of tramadol and asparatic acid, n-methyl-receptor antagonist |
| 07/06/1999 | US5919823 Treatment of secondary movement disorders using large neutral amino acids |
| 07/06/1999 | US5919822 Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients |
| 07/06/1999 | US5919821 Plant extract |
| 07/06/1999 | US5919820 Antioxidant medicament |
| 07/06/1999 | US5919819 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 07/06/1999 | US5919818 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 07/06/1999 | US5919816 Administering drug with protective agent |
| 07/06/1999 | US5919815 Taxane compounds and compositions |
| 07/06/1999 | US5919814 Heterocyclic compounds |
| 07/06/1999 | US5919813 Is preferably genistein or an analogue or prodrug thereof |
| 07/06/1999 | US5919812 Therapy for reducing mammary tissue in males |
| 07/06/1999 | US5919811 Neurodegenerative disorders |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919809 3-substituted-2-oxindole derivatives |
| 07/06/1999 | US5919808 Compositions and methods for treating bone deficit conditions |
| 07/06/1999 | US5919807 Benzothiazoles and benzoxazoles, drugs containing them, their use and methods of preparing them |
| 07/06/1999 | US5919806 Medicines for cardiac insufficiency |
| 07/06/1999 | US5919805 Hetrocyclic compounds and their preparation and use |
| 07/06/1999 | US5919804 Use of levobupivacaine in facial surgery |
| 07/06/1999 | US5919803 3-benzylamino-2-phenylpiperidines as neurokinin antagonists |
| 07/06/1999 | US5919802 Methods of preventing and/or treating temporal lobe epilepsy |
| 07/06/1999 | US5919801 N-substituted piperidines as PDE4 inhibitors |
| 07/06/1999 | US5919800 Benzothiophene compounds, intermediates, compositions, and methods |
| 07/06/1999 | US5919798 4-heteroaryl-1-piperidinealkanols and derivatives thereof and their therapeutic utility |
| 07/06/1999 | US5919795 Atherosclerosis therapy |
| 07/06/1999 | US5919794 Methods of using pharmaceutical tetrahydroisoquinolines |
| 07/06/1999 | US5919793 Quinuclidine derivatives, squalene synthetase inhibitors, anticholesterol agents |
| 07/06/1999 | US5919791 Ellipticine compounds |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919788 4-(1H-indol-1-yl)-1-piperidinyl derivatives |
| 07/06/1999 | US5919787 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 07/06/1999 | US5919786 N,N-disubstituted amic acid derivatives |
| 07/06/1999 | US5919784 Anxiety, depression |
| 07/06/1999 | US5919781 Use of NK-1 receptor antogonists for treating substance use disorders |
| 07/06/1999 | US5919779 5,6-Heteroaryl-dipyrido(2,3-B:3', 2'-F) azepines and their use in the prevention or treatment of HIV infection |
| 07/06/1999 | US5919778 Alzheimer*s disease |
| 07/06/1999 | US5919776 Antiinflammatory agent; autoimmune disease |
| 07/06/1999 | US5919775 Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
| 07/06/1999 | US5919774 Novel compounds such as 2-(1-benzyl-2,5-dimethyl-4-(2-carboxyphenylmethyl)pyrrol-3-yl) glyoxamide for inhibiting human nonpancreatic secretory phospholipase a2 (spla2) mediated release of fatty acids in a mammal |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919772 Oligonucleotide complementary to dna methyltransferase mrna. |
| 07/06/1999 | US5919770 20-o-(glucopyranosyl)-20(s)-protopanaxadiol as antitumor agent |
| 07/06/1999 | US5919767 Adjust protein concnetration in muscles |
| 07/06/1999 | US5919760 Method for treating acute and severe diarrhea |
| 07/06/1999 | US5919755 Medical use of heme products |
| 07/06/1999 | US5919701 Oligonucleotides with activity against human immunodeficiency virus |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell |
| 07/06/1999 | US5919490 Stimulating blood circulation to skin |
| 07/06/1999 | US5919489 Process for aqueous granulation of clarithromycin |
| 07/06/1999 | US5919485 Oral 2-methyl-thieno-benzodiazepine formulation |
| 07/06/1999 | US5919483 Antioxidant-containing effervescent composition |
| 07/06/1999 | US5919482 Soft capsules; containiong liquid paraffin |
| 07/06/1999 | US5919479 Noninvasive dermal anesthetics |
| 07/06/1999 | US5919477 Two jutaposed devices |
| 07/06/1999 | US5919473 Analgesic drug delivery |
| 07/06/1999 | US5919470 21 to about 40 wt-% urea with skin protectants of an oleaginous nature for treating a variety of dermatological conditions manifested by dry skin. the composition does not require use of traditional preservatives. |
| 07/06/1999 | US5919469 Products derived from 2-imino-2,3-dihydro-1H-indoles, processes for their preparation, their use in cosmetics and cosmetic compositions using them |
| 07/06/1999 | US5919465 Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) |
| 07/06/1999 | US5919464 Controlling cell differentiation |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | US5919442 Hyper comb-branched polymer conjugates |
| 07/06/1999 | US5919438 Combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside |
| 07/06/1999 | US5919400 Organic mercaptan, sulfide or disulfide stabilizer |
| 07/06/1999 | CA2177146C Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 07/06/1999 | CA2157397C Indole derivatives as 5-ht1-like agonists for use in migraine |
| 07/06/1999 | CA2153396C Compositions and uses thereof |
| 07/06/1999 | CA2131991C Treatment of migraine |
| 07/06/1999 | CA2130762C Treatment of disease and conditions associated with macrophage infiltration |
| 07/06/1999 | CA2092270C Ultraviolet screening composite oxide and process for producing the same |
| 07/06/1999 | CA2082296C Process for the preparation of stable, complex emulsion systems of the water-oil-type and their use as cosmetic preparations |
| 07/06/1999 | CA2017920C Beta-lactam elastase inhibitors |
| 07/06/1999 | CA2011063C Nicardipine pharmaceutical composition for parenteral administration |
| 07/06/1999 | CA2009578C Excitatory amino acid receptor antagonists |
| 07/06/1999 | CA1340638C Cephalosporin derivatives |
| 07/06/1999 | CA1340631C N- (5,6,7,8-tetrahydropyrido [2,3-d] pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032606A2 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032506A1 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES |
| 07/01/1999 | WO1999032503A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 07/01/1999 | WO1999032497A1 Phosphonocephem derivatives, process for the preparation of the same, and use thereof |
| 07/01/1999 | WO1999032493A1 Process for purifying a solution of an ampicillin pro-drug ester |
| 07/01/1999 | WO1999032491A1 Novel acronycine derivatives, preparation method and pharmaceutical compositions |
| 07/01/1999 | WO1999032487A1 Kv2.1 ANTAGONISTS |